Qinwei Zhou
Chief Operating Officer
pharmaceutical
Innovent Biologics
China
Biography
Dr. Zhou has over 25 years of biotech and biopharma experience, including more than 18 years of industry executive management experience spanning research, clinical and commercial stages. Prior to his current position at Innovent, he was Vice President at ImClone and Vice President at Eli Lilly and Company New Jersey. He has extensive contributions to IND and BLA submissions as evidenced with the approval of Erbitux, Cyramza, Portrazza and many other biologics around the world. Dr. Zhou earned his Ph.D. from New York University.
Research Interest
pharmaceutical
